510(k) Report

FDA applicant

Clearmind Biomedical

Taipei, TW3 decisions2020–20230 recalls

FDA records 3 decisions for Clearmind Biomedical (Taipei, TW) from 2020 to 2023: 3 510(k) clearances. All are in product code GWG (Endoscope, Neurological). Its devices cite 5 predicates, 1 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, neurology panel, where it files most

How often FDA has decided Clearmind Biomedical’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2020: 12021: 12023: 1
2020high 1 (2020) · low 0 (2022)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2020.

FIG. 1 — Clearmind Biomedical by year, 2020–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Clearmind Biomedical’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Which product codes does it file in?

  • GWGEndoscope, Neurological3decisions

Whose devices does it build on?

Its devices cite 5 predicates; 1 are its own earlier devices. The firms it cites most:

Which of its devices are cited most?

Its devices that later submissions most often claim equivalence to.

  • K201308Axonpen, Axonmonitor, Axonbox, TabletClearmind Biomedical · 20201cites it

What has FDA decided for it lately?

  • K230125Neuroblade SystemClearmind Biomedical · 2023
  • K210251ClearPath Disposable IntroducerClearmind Biomedical · 2021
  • K201308Axonpen, Axonmonitor, Axonbox, TabletClearmind Biomedical · 2020

All 3 as Clearmind Biomedical →